You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NANDROLONE PHENPROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nandrolone Phenpropionate, and what generic alternatives are available?

Nandrolone Phenpropionate is a drug marketed by Watson Labs and is included in two NDAs.

The generic ingredient in NANDROLONE PHENPROPIONATE is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NANDROLONE PHENPROPIONATE?
  • What are the global sales for NANDROLONE PHENPROPIONATE?
  • What is Average Wholesale Price for NANDROLONE PHENPROPIONATE?
Summary for NANDROLONE PHENPROPIONATE
Drug patent expirations by year for NANDROLONE PHENPROPIONATE

US Patents and Regulatory Information for NANDROLONE PHENPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs NANDROLONE PHENPROPIONATE nandrolone phenpropionate INJECTABLE;INJECTION 086386-001 Jun 17, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs NANDROLONE PHENPROPIONATE nandrolone phenpropionate INJECTABLE;INJECTION 087488-001 Jun 17, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NANDROLONE PHENPROPIONATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Nandrolone Phenylpropionate

Introduction

Nandrolone phenylpropionate, commonly known as NPP or nandrolone phenpropionate, is an androgen and anabolic steroid used in various medical and athletic contexts. This article delves into the market dynamics and financial trajectory of this drug, exploring its current market status, future projections, and the factors influencing its growth.

Medical Uses of Nandrolone Phenylpropionate

Nandrolone phenylpropionate has been primarily used in the treatment of advanced breast cancer in women and as an adjunct therapy for senile or postmenopausal osteoporosis. It is also utilized for its anabolic effects, particularly in cases of muscular atrophy and other chronic illnesses[2].

Market Size and Growth

While specific financial data for nandrolone phenylpropionate is not as readily available as for its more widely used counterpart, nandrolone decanoate, we can infer market trends from the broader anabolic steroid market. The global market for anabolic steroids, including nandrolone decanoate, is expected to grow significantly, driven by increasing demand from medical and sports industries. For instance, the nandrolone decanoate market is projected to reach USD 140.71 billion by 2031, growing at a CAGR of 5% from 2024 to 2031[1].

Market Segmentation

The market for nandrolone phenylpropionate can be segmented based on its types and applications. Here are the key segments:

By Type

  • Injectable Grade: This is the most common form of nandrolone phenylpropionate, administered via intramuscular injection.
  • Pharmaceutical Grade: Used in medical treatments, this grade ensures high purity and efficacy.
  • Research Grade: Utilized in scientific research and development of new therapeutic avenues[1].

By Application

  • Anabolic Steroids: Used to enhance muscle mass and physical performance.
  • Muscle Building: Popular among athletes and bodybuilders.
  • Hormone Therapy: Used in the treatment of hormonal imbalances.
  • Sports Medicine: To improve athletic performance and aid in recovery[1].

Geographical Distribution

The market for nandrolone phenylpropionate is spread across various geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Each region has its own set of regulatory frameworks, market demands, and competitive landscapes that influence the drug's market dynamics.

Regulatory Environment

The regulatory environment plays a crucial role in the market dynamics of nandrolone phenylpropionate. Regulatory approvals and changes in policy can significantly impact the drug's availability and market share. For instance, stricter FDA scrutiny of generic drug applications can raise the cost of obtaining approval, affecting the number of competitors and ultimately the price of the drug[4].

Competitive Landscape

The competitive landscape for nandrolone phenylpropionate includes several key players, although it is less competitive compared to nandrolone decanoate. Companies like Organon International, Pfizer Inc., and various generic pharmaceutical companies are involved in the production and distribution of anabolic steroids. The market share of these companies, new product launches, collaborations, and expansions are critical factors in understanding the competitive dynamics[1].

Pharmacokinetics and Efficacy

Nandrolone phenylpropionate is known for its strong anabolic effects and weak androgenic effects, making it suitable for use in women and children. It has a shorter elimination half-life and duration of action compared to nandrolone decanoate, typically lasting around 5-7 days when administered via intramuscular injection[2].

Side Effects and Safety Profile

The drug is associated with side effects such as virilization in women, including acne, increased hair growth, voice changes, and increased sexual desire. However, these side effects are relatively uncommon at recommended dosages. The safety profile of nandrolone phenylpropionate is generally favorable, especially when compared to other anabolic steroids[2].

Market Drivers

Several factors drive the market for nandrolone phenylpropionate:

Medicinal Uses

The drug's effectiveness in treating chronic illnesses and muscular atrophy is a significant driver. Its use in hormone therapy and as an adjunct treatment for osteoporosis further enhances its market appeal[1][2].

Fitness and Sports Trends

The global trend of increased fitness awareness and the demand for performance-enhancing medications are key drivers. Athletes and bodybuilders seek anabolic steroids to improve physical performance, contributing to the drug's market growth[1].

Pharmaceutical Innovations

Advancements in pharmaceutical technology, such as innovative formulations and drug delivery methods, improve the efficacy and attractiveness of the medication. Regulatory support and rising healthcare costs also contribute to the market dynamics[1].

Market Challenges

Despite the growth potential, the market for nandrolone phenylpropionate faces several challenges:

Regulatory Hurdles

Stricter regulations and increased scrutiny by regulatory bodies can limit the drug's availability and increase the cost of obtaining approvals[4].

Competition from Other Steroids

The market is competitive, with other anabolic steroids like nandrolone decanoate dominating the landscape. This competition can affect the market share of nandrolone phenylpropionate[1].

Side Effects and Safety Concerns

While the safety profile is generally favorable, the potential for side effects, especially at higher dosages or with long-term use, can deter some users and impact market growth[2].

Financial Projections

Given the broader market trends for anabolic steroids, it is reasonable to expect that nandrolone phenylpropionate will see steady growth, albeit at a slower pace than nandrolone decanoate. The financial trajectory will be influenced by the drug's medicinal uses, its popularity in the sports and fitness sectors, and advancements in pharmaceutical technology.

Key Takeaways

  • Growing Demand: Increasing demand from medical and sports industries drives the market for nandrolone phenylpropionate.
  • Regulatory Influence: Regulatory approvals and changes in policy significantly impact the drug's market dynamics.
  • Competitive Landscape: The market is less competitive compared to nandrolone decanoate but still involves several key players.
  • Pharmacokinetics and Efficacy: The drug's strong anabolic effects and favorable safety profile contribute to its market appeal.
  • Market Drivers: Medicinal uses, fitness and sports trends, and pharmaceutical innovations are key drivers.

FAQs

What are the primary medical uses of nandrolone phenylpropionate?

Nandrolone phenylpropionate is primarily used in the treatment of advanced breast cancer in women and as an adjunct therapy for senile or postmenopausal osteoporosis. It is also used for its anabolic effects in cases of muscular atrophy and other chronic illnesses[2].

How does the regulatory environment impact the market for nandrolone phenylpropionate?

The regulatory environment plays a crucial role in the market dynamics of nandrolone phenylpropionate. Stricter FDA scrutiny and changes in policy can affect the drug's availability and market share[4].

What are the key drivers of the market for nandrolone phenylpropionate?

The key drivers include the drug's medicinal uses, increasing demand from the sports and fitness sectors, and advancements in pharmaceutical technology[1][2].

What are the potential side effects of nandrolone phenylpropionate?

The drug is associated with side effects such as virilization in women, including acne, increased hair growth, voice changes, and increased sexual desire. These side effects are relatively uncommon at recommended dosages[2].

How does nandrolone phenylpropionate compare to nandrolone decanoate in terms of market size and growth?

Nandrolone decanoate has a larger market size and growth potential compared to nandrolone phenylpropionate. However, nandrolone phenylpropionate still sees steady growth driven by its medicinal uses and popularity in the sports sector[1].

Sources

  1. Market Research Intellect: Nandrolone Decanoate Market Size, Share, Trends, Analysis, 2031.
  2. Wikipedia: Nandrolone phenylpropionate.
  3. The Journal of Clinical Endocrinology & Metabolism: Pharmacokinetic Evaluation of Three Different Intramuscular Doses of Nandrolone Decanoate.
  4. Federal Trade Commission: Generic Drug Industry Dynamics.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.